Viatris, Ocuphire get FDA approval for Ryzumvi eye drops to treat mydriasis
The FDA approval was supported by the data from the MIRA trial programme in which the percentage of…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
28 Sep 23
The FDA approval was supported by the data from the MIRA trial programme in which the percentage of…
28 Sep 23
ENTYVIO Is the Only FDA-Approved Ulcerative Colitis Biologic That Offers the Choice of Intravenous or Subcutaneous Maintenance Therapy
27 Sep 23
Reata acquisition bolsters Biogen’s rare disease portfolio with the addition of SKYCLARYS (omaveloxolone), the first and only FDA…
26 Sep 23
The Japanese approval was based on Phase 3 results from Eisai’s large, global Clarity AD clinical trial in…
26 Sep 23
The conditional approval is based on the results from the EPCORE NHL-1 Phase 1/2 trial in which the…
26 Sep 23
The approval was given based on the results from the AReSVi-006 Phase 3 vaccine efficacy trial that enrolled…
26 Sep 23
The acquisition of Decibel builds on prior collaboration between the companies and includes three ongoing gene therapy programs…
25 Sep 23
The approval was based on the data from the EMPA-KIDNEY trial in which Jardiance showed a 28% relative…
25 Sep 23
The EC approval was based on findings from the Phase 2/3 trial conducted in collaboration with the Children’s…
25 Sep 23
First Phase III results in breast cancer for AstraZeneca and Daiichi Sankyo’s datopotamab deruxtecan